136 related articles for article (PubMed ID: 19562876)
21. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model.
Bonhomme F; Lecompte T; Samama CM; Godier A; Fontana P
Eur J Anaesthesiol; 2018 Mar; 35(3):208-214. PubMed ID: 29334511
[TBL] [Abstract][Full Text] [Related]
23. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
24. Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients.
Schmid P; Mordasini A; Luginbühl M; Regli B; Kohler HP; Zimmermann H; Inderbitzin D; Hirt A; Lämmle B; Alberio L
Swiss Med Wkly; 2011; 141():w13213. PubMed ID: 21735365
[TBL] [Abstract][Full Text] [Related]
25. Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series.
Alsayegh F; Fakeir A; Alhumood S; Abdumalek K; Matar H; Samaul I; Nampoory N; Kabalawi H; Mousa SA
Clin Appl Thromb Hemost; 2009; 15(2):225-32. PubMed ID: 18160562
[TBL] [Abstract][Full Text] [Related]
26. Recombinant activated factor VII as a universal haemostatic agent.
Hedner U
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : report on one case and review of other uses in acute leukemias.
Pamuk GE; Taşçi M; Oztürk E; Demir M
Med Oncol; 2010 Mar; 27(1):16-9. PubMed ID: 19137431
[TBL] [Abstract][Full Text] [Related]
28. Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia.
Kurekci AE; Atay AA; Okutan V; Yavuz ST; Ozcan O
Blood Coagul Fibrinolysis; 2005 Mar; 16(2):145-7. PubMed ID: 15741803
[TBL] [Abstract][Full Text] [Related]
29. Recombinant activated factor VII in critical bleeding after orthotopic liver transplantation.
Busani S; Semeraro G; Cantaroni C; Masetti M; Marietta M; Girardis M
Transplant Proc; 2008; 40(6):1989-90. PubMed ID: 18675109
[TBL] [Abstract][Full Text] [Related]
30. Recombinant activated factor VII (Novo7) in patients with ventricular assist devices: case report and review of the current literature.
Heise D; Bräuer A; Quintel M
J Cardiothorac Surg; 2007 Oct; 2():47. PubMed ID: 17963487
[TBL] [Abstract][Full Text] [Related]
31. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
32. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
33. [Recombinant activated factor VII in haemostasis after radical nephrectomy].
Jovanović P; Ivanović D; Timotijević S; Trpković S; Bojović P; Dobricanin V; Cvetković M
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():259-62. PubMed ID: 19562880
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven).
Zülfikar B; Kayiran SM
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):261-3. PubMed ID: 15060424
[TBL] [Abstract][Full Text] [Related]
35. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience.
Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N
J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490
[TBL] [Abstract][Full Text] [Related]
36. [Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures].
Koncar IB; Savić N
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():199-203. PubMed ID: 19562868
[TBL] [Abstract][Full Text] [Related]
37. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
O'Connell NM; Riddell AF; Pascoe G; Perry DJ; Lee CA
Haemophilia; 2008 Jul; 14(4):775-81. PubMed ID: 18384352
[TBL] [Abstract][Full Text] [Related]
38. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
39. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
40. Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.
Matei A; Dolan S; Andrews J; Rivard GÉ
J Obstet Gynaecol Can; 2016 Feb; 38(2):160-3. PubMed ID: 27032741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
